A study to investigate the duration of maintained efficacy in patients with rheumatoid arthritis who had treated with MRA [tocilizumab]
Phase of Trial: Phase III
Latest Information Update: 01 Aug 2012
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 31 Aug 2018 Biomarkers information updated
- 01 Aug 2012 Actual end date (1 May 2010) added as reported by ClinicalTrials.gov.
- 01 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.